Jeff Hull

Jeff Hull has a diverse work experience spanning over several roles and companies. Jeff most recently served as the Senior Director of Market Access, National Accounts at Melinta Therapeutics since October 2021.

Prior to that, Jeff worked at CVS Health as the Director of CVS Caremark PBM/GPO – Trade Relations. In this role, they developed negotiation strategies with pharmaceutical manufacturers and suppliers to drive value through rebates and admin fees. Jeff also took the lead on therapeutic categories such as HIV, Hepatitis B and C, and PCSK9 inhibitors. Jeff worked at CVS Health from December 2020 to June 2021.

From February 2020 to November 2020, Jeff served as the Senior Director of Sales Strategy at Coram CVS/specialty infusion services. In this capacity, they created a long-term vision and strategic growth plan while collaborating with various teams to develop a "Best in Class" service model.

Prior to that, Jeff had an extensive career at Merck. Jeff held roles such as National Account Executive - Infusions, Subacute Account Executive, Strategic Account Leader - Integrated Delivery Systems, and National Pharmacy Account Executive. In these positions, they managed various accounts, developed strategic account plans, and drove sales growth.

Jeff also fulfilled leadership roles during their tenure at Merck, where they managed and trained sales teams of primary care, specialty, and market development reps. Additionally, they held HQ roles as a National Service Center Specialist and Vaccine Marketing Manager.

Overall, Jeff Hull brings a wealth of experience in market access, negotiation, sales strategy, and account management within the pharmaceutical industry.

Jeff Hull attended the University of Tennessee at Martin, but no specific information is available regarding their degree, field of study, start year, or end year at the institution.